Overview

ABCB1/P-glycoprotein Expression as Biologic Stratification Factor for Patients With Non Metastatic Osteosarcoma

Status:
Active, not recruiting
Trial end date:
2021-10-30
Target enrollment:
Participant gender:
Summary
This is a phase II multicentre, uncontrolled trial including patients ≤ 40 years with non-metastatic extremity high-grade osteosarcoma stratified according to P-glicoprotein expression
Phase:
Phase 2
Details
Lead Sponsor:
Italian Sarcoma Group
Treatments:
Acetylmuramyl-Alanyl-Isoglutamine
Cisplatin
Doxorubicin
Ifosfamide
Isophosphamide mustard
Krestin
Liposomal doxorubicin
Methotrexate
Mifamurtide